Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; LRRK2, leucine-rich repeat kinase 2; HTRA2, high temperature requirement protein A2; PD, Parkinson disease; PINK1, PTEN-induced putative kinase 1; IMS, intermembrane space; OMM, outer mitochondrial membr
مقالات ISI MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; AD, Alzheimer′s disease; CR, caloric restriction; FR, food restriction; IF, intermittent fasting; KA, kainic acid; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NOS, nitric oxide synthase; PD, Parkinson′s disease; PTZ, pentylenetetrazole; ROS, react
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; PD, Parkinson׳s disease; CARD, caspase recruitment domain; TUNEL, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling; DLB, dementia with Lewy bodies; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPP±,
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; PD, Parkinson's disease; HD, Huntington's disease; TS, Tourette's syndrome; SNpc and SNpr, substantia nigra pars compacta and pars reticulata; DA, dopamine; HRT, hormone replacement therapy; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MA, methamph
Medicinal plant Combretum leprosum mart ameliorates motor, biochemical and molecular alterations in a Parkinson's disease model induced by MPTP
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; DA, Dopamine; DAT, Dopamine Transporter; DOPAC, 3,4-Dihydroxyphenylacetic Acid; PD, Parkinson's Disease; C.l.EE, Combretum Leprosum Ethanolic Extract; HVA, Homovanillic Acid; MPTP, 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine; TH, Tyrosine HydroxilaseComb
Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; ChAT, choline acetyl transferase; DA, dopaminergic; Dtx-UII, diphtheria toxin coupled to urotensin II; Iba-1, ionized calcium-binding adaptor molecule 1; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NADPH, nicotinamide adenine dinucleotide phosphat
Silibinin suppresses astroglial activation in a mouse model of acute Parkinson׳s disease by modulating the ERK and JNK signaling pathways
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; MPTP, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Parkinson׳s disease; MPP+, 1-methyl-4-phenylpyridine; TH, Tyrosine hydroxylase; GFAP, Glial fibrillary acidic protein; Iba-1, Ionized calcium binding adapter molecule-1MPTP; Astrocyte; Parkinson׳s di
A quantitative LC–MS/MS method for determination of thiazolidinedione mitoNEET ligand NL-1 in mouse serum suitable for pharmacokinetic studies
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; %CV, percent coefficient of variation; IS, internal standard; LLOQ, lower limit of quantification; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MRM, multiple reaction monitoring; NL-1, 5-[3,5-di-tert-butyl-4-hydroxyphenyl)methyl]-1,3-thiazolidine-2
Indirect application of near infrared light induces neuroprotection in a mouse model of parkinsonism – An abscopal neuroprotective effect
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; GFAP, glial fibrillary acidic protein; IBA1, ionized calcium-binding adapter molecule 1; LED, light-emitting device; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NIr, near infrared light; PBM, photobiomodulation; SNc, substantia nigra pars compacta
Reverse microdialysis of a 5-HT2A receptor antagonist alters extracellular glutamate levels in the striatum of the MPTP mouse model of Parkinson’s disease
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; L-DOPA, L-3,4-dihydroxyphenylalanine; 5-HT, serotoninGlutamate; M100907; Microdialysis; Parkinsonism; MPTP; Serotonin
Downregulation of miR-124 in MPTP-treated mouse model of Parkinson’s disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; cdk5, cyclin-dependent kinase 5; DAT, dopamine transporter; DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; H2O2, hydrogen peroxide; miRNA, microRNA; MPP, methyl phenyl pyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PBS
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; 6-OHDA, 6-hydroxy-dopamine; AIMs, abnormal involuntary movements; DA, dopamine; LID, L-DOPA-induced dyskinesia; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Parkinson's disease; TH, tyrosine hydroxylaseDyskinesia; L-DOPA; Parkinson's disease; 6
5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; 6-OHDA, 6-hydroxydopamine; AIMs, Abnormal involuntary movements; DA, Dopamine; L-DOPA, L-3,4-dihydroxyphenylalanine; LID, L-DOPA-induced dyskinesia; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Partkinson's disease6-OHDA; Dopamine; Serotonin; L
Antiparkinsonian activity of some 9-N-, O-, S- and C-derivatives of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; CC, column chromatography; DMF, dimethylformamide; DMSO, dimethylsulfoxide; l-DOPA, l-3,4-dihydrophenylalanine; MAO, monoamine oxidase; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NBS, N-bromosuccinimide; PD, Parkinson’s disease; r.t., room temper
Dopamine and its metabolites in cathepsin D heterozygous mice before and after MPTP administration
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPP+, 1-methyl-4-phenylpyridinium; 3-MT, 3-methoxytyramine; MHPG, 3-methoxy-4-hydroxyphenylglycol; DOPAC, 3,4-dihydroxymethylphenylacetic acid; 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, 5-hydroxytryptami
Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: Insights from a transgenic mouse model
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; aSyn, α-synuclein; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; DD, dark–dark; DA, dopamine; FDR, fast delayed rectifier; GABA, gamma-aminobutyric acid; BK, large‐conductance Ca2 + activated K+ channels; LD, light–dark; MAO, Monoamine oxidase; PVN,
Increased vulnerability of parkin knock down PC12 cells to hydrogen peroxide toxicity: The role of salsolinol and NM-salsolinol
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; AR-JP, autosomal recessive juvenile Parkinson’s disease; COMT, catechol-O-methyltransferase; DOPAC, 3,4-dihydroxyphenylacetic acid; HVA, homovanillic acid; MAO, monoamine oxidase; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MTT, methylthiazol tetr
Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; PD, Parkinson disease; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; POLG, polymerase gamma; UPDRS, unified Parkinson disease rating scale; HY, Hoehn and Yahr scale; PIGD, postural instability and gait difficulty; TD, tremor dominantParkinsonism; Po
Amelioration of rotenone-induced dopaminergic cell death in the striatum by oxytocin treatment
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; OT, oxytocin; PD, Parkinson's disease; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; OTR, oxytocin receptors; DMSO, dimethyl sulfoxide; SNc, substantia nigra pars compacta; VTA, ventral tegmental area; TH, tyrosine hydroxylase; Bcl-2, B-cell lymphom
Partial dopamine depletion in MPTP-treated mice differentially altered motor skill learning and action control
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; DA, dopamine; DAT, dopamine transporter; ERK, extracellular signal-regulated kinase; i.p, intraperitoneal; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Parkinson's disease; s.c, subcutaneous; TH, tyrosine hydroxylaseAccelerating rotarod; Motor
Cellular localization of dopamine receptors in the gastric mucosa of rats
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; Dopamine receptor; Gastric mucosa; Immunofluorescent; Chief cell; Parietal cellDA, dopamine; IR, immunoreactivity; GI, gastrointestinal; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; real-time RT-PCR, real-time reverse-transcription polymerase chain
Differential susceptibility to the PPAR-γ agonist pioglitazone in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 6-hydroxydopamine rodent models of Parkinson's disease
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; MAO-B, monoamine oxidase-B; PPAR, peroxisome proliferator-activated receptor; SNc, substantia nigra pars compacta; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 6-OHDA, 6-hydroxydopamine; VTA, ventral tegmental area; TH, tyrosine hydroxylasePPAR; Pi
Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP+-induced mitochondrial dysfunctions in neuronal cells
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; SDM, serum deficient media; CM, complete media; MPP+, 1-methyl-4-phenylpyridinium ion; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; SN, substantia nigra; ST, striatum; DN, dopaminergic neuron; TH, tyrosine hydroxylase; CMAPS, cell-based mitochondri
Voltage-gated calcium channels and Parkinson's disease
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; Ca2+, calcium ion; CaV, voltage-gated calcium channel; L-DOPA, L-3,4-dihydroxyphenylalanine; 6-OHDA, 6-hydroxydopamine; mRNA, messenger RNA; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PCR, polymerase chain reaction; RT, reverse transcription; SN,
Animal models of l-DOPA–induced dyskinesia: an update on the current options
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; l-DOPA-induced dyskinesia; 6-OHDA; MPTP; animal models; abnormal involuntary movements; Parkinson's diseaseAIMs, abnormal involuntary movements; LID, l-DOPA-induced dyskinesia; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MFB, medial forebrain bund
Targeting oxidative stress, mitochondrial dysfunction and neuroinflammatory signaling by selective cyclooxygenase (COX)-2 inhibitors mitigates MPTP-induced neurotoxicity in mice
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; ANOVA, analysis of variance; COX, cyclooxygenase; HEPES, 5-hydroxytryptamine (5-HT); i.p., intraperitoneal; iNOS, inducible nitric oxide synthase; MAO, monoamine oxidase; MDA, malondialdehyde; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MTT, 3-(4,
Changes of gene expression profiles in the cervical spinal cord by acupuncture in an MPTP-intoxicated mouse model: Microarray analysis
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; DTT, dithiothreitol; DAT, dopamine transporter; 6-OHDA, 6-hydroxydopamine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Parkinson's disease; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; SNpc, substantia nigra pars compac
Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; DA, dopamine; DAT, dopamine transporter; TH, tyrosine hydroxylase; SN-PC, substantia nigra pars compacta; PRAC, parallel rod activity chamber; ANOVA, analysis of varianceTyrosine hydroxylase; Dopamine; D
Six questions on the subthalamic nucleus: lessons from animal models and from stimulated patients
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; basal ganglia; OCD; perseveration; motivation; DBS; high-frequency stimulationDBS, deep brain stimulation; HFS, high-frequency stimulation; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Parkinson's disease; STN, subthalamic nucleus; 5-CSRTT, 5-c
Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; PD, Parkinson's disease; SN, substantia nigra; LPS, lipopolysaccharide; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NOS, nitric oxide synthase; LRRK2, Leucine-rich repeat kinase 2; PINK1, PTEN-induced putative kinase 1; GWAS, genome-wide associati
Time course of MPTP toxicity on translational control protein expression in mice brain
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; eIF2α, eukaryotic initiation factor 2α; mTOR, mammalian target of rapamycin; PKR, double-stranded RNA-protein dependent kinase; p70S6K, ribosomal p70S6 kinase; MPP+, 1-methyl-4-phenylpyridinium ion; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD,
Nest building performance following MPTP toxicity in mice
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; DA, dopamine; DAT, dopamine transporter; DOPAC, 3,4-dihydroxyphenylacetic acid; HVA, homovanilic acid; l-DOPA, l-3,4-dihydroxyphenylalanine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Parkinson's disease; SEM, standard error of the mean; TH,
The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: Clinical relevance
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; DA, dopamine; DOPAC, dihydroxyphenylacetic acid; GSH, glutathione; MAO-B, monoamine oxidase-B; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPP+, 1- methyl-4-phenylpyridinium; TH, tyrosine hydroxylaseZonisamide; Epilepsy; MPTP; MAO-B; Mice; Parkins
Striatal ablation of GABAergic neurons prevents the in vivo neuroprotective effect of DCG-IV against the MPP+-induced neurotoxicity on dopaminergic nerve terminals
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; BDNF, brain-derived neurotrophic factor; DCG-IV, 2S:2′R:3′R:-2-(2′3′-dicarboxycycloropropyl)glycine; MPP+, 1-methyl-4-phenylpyridinium ion; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; QA, quinolinic acidDopamine microdialysis; Quinolinic acid lesi
Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; PD, Parkinson's disease; SN, substantia nigra; NMDA, N-methyl-d-aspartate; IGF-1, insulin-like growth factor-1; CNS, central nervous system; MPP+, 1-methyl-4-phenylpyridiniumion; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; GSK-3beta, glycogen synt
Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Parkinson's disease; PFC, prefrontal cortex; NER, normalized expression rate; FDR, false discovery rateMicroarray; Quantitative PCR; Monkey; Human; Parkinson's disease; MPTP; Brain; Prefrontal cortex
Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; Akt, protein kinase B; BSA, bovine serum albumin; DA, dopamine; GSK3, glycogen synthase kinase-3; 6-OHDA, 6-hydroxydopamine; L-Dopa, Levodopa; LID, L-Dopa-induced dyskinesias; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; mTORC2, mTOR complex 2; NMD
Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; PD, Parkinson's disease; MPP+, 1-methyl-4-phenyl pyridinium; PI3K, phosphatidylinositol 3-kinase; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; COX, cyclooxygenase; NSAIDs, nonsteroidal antiinflammatory drugs; MEK, MAP-ERK kinase; MAP, mitogen activ
Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; PD, Parkinson's disease; DA, dopamine; MPP+, 1-methyl-4- phenylpyridinium ions; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; GSH, glutathione; MDA, malondialdehyde; SNpc, substantia nigra pars compact; ROS, reactive oxygen species; SOD, superoxide
Adenosine A1 receptors contribute to mitochondria vulnerability to pro-oxidant stressors
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; MPP+, l-methyl-4-phenylpyridinium; RTN, rotenone; PQ, paraquat; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; A1ko, A1 knock-out; N0840, N6-cyclopentyl-9-methyladenine; CCPA, 2-chloro-N6-cyclopentyladenosine; DCFH-DA, dichlorofluorescin diacetate; C
Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; DA, dopamine; DSP-4, N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine; ISI, interspike interval; ISIH, interspike interval histogram; LC, locus coeruleus; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NA, noradrenalin; PBS, phosphate buffered saline; PD
VTA neurons show a potentially protective transcriptional response to MPTP
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; LCM, Laser capture microdissection; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; SN, substantia nigra; VTA, ventral tegmental areaMicroarray; Substantia nigra; Ventral tegmental area
Cause and consequence: Mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; AD, Alzheimer's Disease; APP, amyloid precursor protein; Aβ, amyloid β peptide; KGDHC, α-ketoglutarate dehydrogenase complex; ETC, electron transport chain; Htt, huntingtin; HD, Huntington's Disease; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3NP
Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; AREs, androgen receptor binding sites; β-TrCP, β-transducin repeat-containing protein; GO, Gene Ontology; REST, RE1-silencing transcription factor; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; SN, substantia nigra pars compacta; STR, striatum; TCF7
Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; PD, Parkinson's disease; DA, dopamine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; SNpc, substantia nigra pars compacta; TH, tyrosine hydroxylaseParkinson's disease; Substantia nigra; Dopamine; Synaptic zinc; Apoptosis
DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; ASK1, apoptosis signal-regulating kinase 1; Hsp, heat shock protein; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MPP+, 1-methyl-4-pyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; PD, Parkinson's disease; PGC-1α, pe
Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; PD, Parkinson's disease; DA, dopaminergic; SNc, substantia nigra pars compacta; NMDA, N-methyl-d-aspartate; DNQX, 6,7-dinitroquinoxaline-2,3(1H,4H)-dione; MAPK, mitogen-activated protein kinase; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; JNK, c-J
Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; BSA, bovine serum albumin; DAPI, 4′,6-diamidino-2-phenylindole; DMEM, Dulbecco's modified essential medium; FBS, fetal bovine serum; GFAP, glial fibrillary acidic protein; HS, horse serum; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NeuN, neuron-s
Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; SN, substantia nigra; PD, Parkinson's disease; MPP+, 1-methyl-4-phenylpyridinium; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; DMT1, divalent metal transporter 1; IRE, iron responsive element; TfR, transferrin receptor; UTR, untranslational region;
Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration
Keywords: MPTP، 1-methyl-4-phenyl-1،2،3،6-tetrahydropyridine; AD, Alzheimer's disease; CAD, Cath.a differentiated; C2-ceramide, N-acetyl-sphingosine; mPTP, mitochondrial permeability transition pore; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MTT, 3-(4,5-dimethyl-thiazol-2yl)-2,5-diphenyltetrazolium bromide